VYNE Therapeutics (VYNE) Cash from Investing Activities (QoQ) (2017 - 2025)
VYNE Therapeutics (VYNE) Cash from Investing Activities (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -76.43% |
| Mar 31, 2025 | 55.68% |
| Dec 31, 2024 | 364.05% |
| Sep 30, 2024 | -125.36% |
| Jun 30, 2024 | 632.92% |
| Mar 31, 2024 | 94.28% |
| Mar 31, 2023 | 499,900.00% |
| Dec 31, 2022 | 101.16% |
| Jun 30, 2020 | -67.98% |
| Mar 31, 2020 | 993.47% |
| Dec 31, 2019 | 229.01% |
| Sep 30, 2019 | -114.27% |
| Jun 30, 2019 | 323.48% |
| Mar 31, 2019 | -57.12% |
| Dec 31, 2018 | 117.57% |
| Sep 30, 2018 | 6.84% |
| Jun 30, 2018 | 116.93% |
| Mar 31, 2018 | -830.93% |
| Dec 31, 2017 | 117.29% |
| Sep 30, 2017 | -593.96% |